We are pleased to inform you that Acellmed and its corneal project have been noticed in #HuaweiStartupChallenge3, organized by @Huawei Polska and @Startup Academy. After successfully passing the first two stages of the competition, we are among 20 finalists – the best Polish startups (selected out of 168!). Congrats to other startups who qualified for…
On December 2, during a meeting at the Silesian Center for Entrepreneurship, Acellmed received a distinction as a LEADER OF CHANGE in the medical category. Five companies were awarded, including ACM as the only company in this category.
…
We are pleased to announce that on 08/11/2022 a Scientific Cooperation Agreement was signed between the M. Skłodowska-Curie National Research Institute of Oncology Gliwice Branch and the consortium: Acellmed Sp. z o.o. and Silesian Park of Medical Technology Kardio-Med Silesia. The scientific cooperation will consist in verifying the therapeutic activity and specificity of action of the anti-acute myeloid leukemia (AML) drug being developed by the Acellmed – ŚPTM Kardio-Med Silesia consortium on leukemic cells of AML patients being treated at the M. Skłodowska-Curie National Research Institute of Oncology Gliwice Branch.
…
Nearly 150 applications were submitted to the prestigious Start-up Challenge 2022 competition, organized within the framework of 14th European Economic Congress. As a result, the most interesting start-ups, divided into five contest categories, were selected. The best 15, who qualified for the semi-finals, presented their work to a broad audience during the European Economic Congress,…
We are pleased to announce that Acellmed has been qualified as one of the 15 start-ups to the semi-finals of the Start-up Challenge 2022 competition and will be presented during the XIV European Economic Congress on 25-27.04.2022. We will present our company in the category HEALTH & BIOTECHNOLOGY – Medicine, health, medical technology, pharmacy, biotechnology.…
For the second time Acellmed as one of the companies from the Silesia region has been selected and qualified to participate in a foreign trade mission. This time we will present our company in Italy between 9th and 13th of May 2022. The mission is organized under the project “Economic promotion of the region and…
Acellmed, as one of the six selected companies, will participate in the Polish-Arabic Economic Forum, held from January 28 – February 1, 2022, in Dubai, within the framework of the project “Economic promotion of the region and activities related to the creation of friendly conditions for investment export.” The forum’s primary purpose is to promote…
We are proud to announce that the consortium Acellmed – Silesian Park of Medical Technology – University of Wroclaw received funding in “The Competition for the development of innovative therapeutic solutions using RNA technology” (ABM/2021/5), organized by the Medical Research Agency Our project, entitled “Mutation-resistant nanotherapeutics inhibiting infection progress of RNA-virus, SARS-CoV-2” received the highest…
We are pleased to announce that Acellmed’s project, submitted together with the Silesian Park of Medical Technology Kardio-Med Silesia, was ranked 1st on the list of the best projects in the competition organized by the Silesian Centre for Entrepreneurship (European Regional Development Fund under the Regional Operational Programme of the Silesian Voivodeship for 2014-2020 from…
